| Interim study: comparison of safety and efficacy of levofloxacin plus colistin regimen with levofloxacin plus high dose ampicillin/sulbactam infusion in treatment of ventilator … R Mosaed, M Haghighi, M Kouchak, MM Miri, S Salarian, S Shojaei, ... Iranian Journal of Pharmaceutical Research: IJPR 17 (Suppl2), 206, 2018 | 22 | 2018 |
| Cost-effectiveness of alemtuzumab and natalizumab for relapsing-remitting multiple sclerosis treatment in Iran: decision analysis based on an indirect comparison S Taheri, MA Sahraian, N Yousefi Journal of Medical Economics 22 (1), 71-84, 2019 | 17 | 2019 |
| Teriparatide in the treatment of severe postmenopausal osteoporosis: a cost-utility analysis S Taheri, FM Fashami, F Peiravian, N Yousefi Iranian journal of pharmaceutical research: IJPR 18 (2), 1073, 2019 | 9 | 2019 |
| Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience B Fatemi, S Rezaei, S Taheri, F Peiravian Expert Review of Pharmacoeconomics & Outcomes Research 21 (4), 775-784, 2021 | 7 | 2021 |
| A systematic review of clinical practice guidelines for castration-resistant prostate cancer MJF Moghadam, S Taheri, F Peiravian Iranian Journal of Pharmaceutical Research: IJPR 17 (Suppl), 17, 2018 | 7 | 2018 |
| Efficacy and safety of dulaglutide compared to liraglutide: A systematic review and meta-analysis in patients with type 2 diabetes mellitus S Taheri, A Saffaei, B Amani, A Akbarzadeh, F Peiravian, N Yousefi Iranian journal of pharmaceutical research: IJPR 18 (4), 2180, 2019 | 5 | 2019 |
| COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN TREATMENT OF PATIENTS WITH HEART FAILURE IN IRAN. S Taheri, E Heidari, MA Aivazi, M Shams-Beyranvand, M Varmaghani International Journal of Technology Assessment in Health Care 34 (6), 576-583, 2018 | 5 | 2018 |
| Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis N Ayati, S Taheri, MA Sahraian, S Nikfar Current Journal of Neurology 20 (3), 154, 2021 | 3 | 2021 |
| Biosimilar Medicines in the Iranian Market: a Way to More Affordable Medicines. N Yousefi, R Ahmadi, H Tayeba, S Taheri, F Mahboudi, F Peiravian Indian Journal of Pharmaceutical Sciences 82 (3), 2020 | 3 | 2020 |
| Cost-effectiveness of Sorafenib for hepatocellular carcinoma: A systematic review MH Motevalli, FPS Taheri Pharm. Pharm. Res. Open Access J 1, 14-21, 2019 | 3 | 2019 |
| Cost-effectiveness analysis of alemtuzumab in comparison with natalizumab, intramuscular interferon beta-1a, subcutaneous interferon beta-1b, and fingolimod for the treatment … S Taheri, N Yousefi, MA Sahraian, G Mehralian Value in Health 20 (9), A723, 2017 | 3 | 2017 |
| Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis S Rezaei, A Taheri, S Taheri, S Kasirzadeh, B Fatemi, MM Sorato Expert Review of Clinical Pharmacology 15 (6), 767-777, 2022 | 2 | 2022 |
| PND45 Ocrelizumab is a cost-effective option for relapsing multiple sclerosis patients, in Iran N Ayati, MA Sahraian, S Taheri, S Nikfar Value in Health 22, S744-S745, 2019 | 2 | 2019 |
| A Cost-effectiveness Analysis of Adding Cetuximab to the First-line Treatment of Metastatic Colorectal Carcinoma in Iran; Considering Genetic Screening for Precision Medicine N Yousefi, A Salimi, G Mohammadnezhad, S Taheri, F Peiravian Journal of Gastrointestinal Cancer 54 (4), 1212-1219, 2023 | 1 | 2023 |
| Cost-effectiveness of dulaglutide versus liraglutide for management of type 2 diabetes mellitus in Iran M Ekhlasi, S Taheri, N Yousefi Value in Health Regional Issues 32, 54-61, 2022 | 1 | 2022 |
| Evaluation of Pharmaceutical System Responsiveness to Non-Therapeutic Needs of Patients using WHO Framework: The Case of Tehran's Outpatient Pharmacies S Sheikhi, S Taheri, N Yousefi, F Pairavian Acta Scientific Pharmaceutical Sciences 2 (12), 44-49, 2018 | 1 | 2018 |
| Cost-effectiveness analysis of long-acting recombinant FSH (Corifollitropin Alfa) versus recombinant FSH (Follitropin Alfa) in assisted reproduction techniques in the … S Taheri, N Tahmasebi Value in Health 20 (9), A521, 2017 | 1 | 2017 |
| Cost-Effectiveness Analysis Of Tigecycline In Comparision With Imipenem/Cilastatin Or Piperacillin/Tazobactam In The Treatment Of Complicated Intra-Abdominal Infections: A … S Taheri, H Mohammadzadeh, G Mehralian Value in Health 20 (9), A789, 2017 | 1 | 2017 |
| Cost-Utility Analysis of Mirabegron Compared to Solifenacin in the Treatment of Overactive Bladder (OAB) in Iran ZK Majd, G Mohammadnezhad, S Taheri, N Yousefi Iranian Journal of Pharmaceutical Research, 2023 | | 2023 |
| Effects of Visual Aspects on Consumer Preferences in The Health Supplement Market by Eye-Tracking: Effect of color and shape in health supplement preferences, Eye tracking method N Tahmasebi, H Vatanpour, F Peiravian, SF Rabinataj, S Taheri Iranian Journal of Pharmaceutical Sciences 18 (4), 345-354, 2022 | | 2022 |
Nazila YousefiAssociate professorVerified email at sbmu.ac.ir
